共 9 条
- [2] Dunnett CW, 1996, STAT MED, V15, P1729
- [5] Morikawa T, 1995, J Biopharm Stat, V5, P297, DOI 10.1080/10543409508835115
- [6] Ng Tie-Hua, 2003, J Biopharm Stat, V13, P629, DOI 10.1081/BIP-120024199
- [7] Phillips A, 2000, DRUG INF J, V34, P337, DOI 10.1177/009286150003400202
- [9] The European Agency for the Evaluation of Medicinal Products, 2000, POINTS CONS SWITCH S